TOUNJIAN ADVISORY PARTNERS, LLC
Position in HALO — Halozyme Therapeutics, Inc.
CIK 2039850
FORT MYERS, FL
Position in HALO
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$1,017
New position
Shares Held
13
first reported quarter
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#622
of 647 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 0%
Shared 0%
None 100%
Position in Biotechnology
Healthcare · as of Jun 30, 2026TOUNJIAN ADVISORY PARTNERS, LLC holds $108,093 across 8 Biotechnology names. HALO ranks #6 (0.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZBIO |
Zenas BioPharma, Inc.
|
2,500 | $63,450 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
49 | $24,339 | |
| 3 | MRNA |
Moderna, Inc.
|
197 | $13,795 | |
| 4 | BNTX |
BioNTech SE
|
45 | $4,187 | |
| 5 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2 | $1,247 | |
| 6 | HALO |
Halozyme Therapeutics, Inc.
This page
|
13 | $1,017 | |
| 7 | RPRX |
Royalty Pharma plc
|
1 | $56 | |
| 8 | CVM |
Cel Sci Corp
|
2 | $2 |
All Filings in HALO
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,017 | 13 | Shares | Sole | 2026-08-07 | |
| No filing history on record for this holder in this stock. | ||||||